NovolinN (TYA Pharmaceuticals)


Welcome to the PulseAid listing for the Novolin drug offered from TYA Pharmaceuticals. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: TYA Pharmaceuticals
NON-PROPRIETARY NAME: Human Insulin
SUBSTANCE NAME: INSULIN HUMAN
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: SUBCUTANEOUS
DOSAGE FORM: INJECTION, SUSPENSION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 1991-07-01
END MARKETING DATE: 0000-00-00


Novolin N HUMAN OTC DRUG Details:

Item DescriptionNovolin N from TYA Pharmaceuticals
LABELER NAME: TYA Pharmaceuticals
DEA SCHEDULE:
ACTIVE STRENGTH: 100([iU]/mL)
START MARKETING DATE: 1991-07-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 64725-1834_88240c8b-10c5-43b4-8a36-020380cea930
PRODUCT NDC: 64725-1834
APPLICATION NUMBER: NDA019959

Other INSULIN HUMAN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
A-S Medication SolutionsHumulin
Eli Lilly and CompanyHumulin
Mannkind CorporationAfrezza
Novo NordiskNovolin
Physicians Total Care, Inc.Humalog 70/30
Sanofi-Aventis U.S. LLCAfrezza
TYA PharmaceuticalsNovolin